Autodesk

Ticker

ADSK

ISIN

US0527691069

Total Trades

875

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News

Autodesk News

Buy
Sell

Autodesk News

Autodesk News
YEARBuySell Net Total Trades
1.67 M USD 3119.06 M USD 9−17.40 M USD41
534,194.00 USD 3137.99 M USD 31−37.46 M USD62
8,833.86 USD 3840.07 M USD 35−40.06 M USD73
— 2726.15 M USD 51−26.15 M USD78
— 3122.47 M USD 45−22.47 M USD76
— 2244.00 M USD 60−44.00 M USD82
— 159.47 M USD 16−9.47 M USD31
— 47.46 M USD 14−7.46 M USD18
— 138.33 M USD 10−8.33 M USD23
16.94 M USD 2062.40 M USD 43−45.46 M USD63
291,800.00 USD 1221.82 M USD 31−21.53 M USD43
2.02 M USD 3416.69 M USD 29−14.67 M USD63
27.74 M USD 4969.74 M USD 52−42.00 M USD101
16.39 M USD 3534.18 M USD 26−17.79 M USD61
1.16 M USD 32.16 M USD 3−997,194.00 USD6
2.57 M USD 245.33 M USD 13−2.76 M USD37
62,590.55 USD 81.73 M USD 6−1.67 M USD14
— 11.10 M USD 2−1.10 M USD3
Buy

CAHILL JOHN T

378,400.00 USD

2,000 × 189.20
Other

Krishnan Ram R.

—

— × —
Buy

rahim rami

—

1,553 × —
Buy

rahim rami

—

466 × —
Buy

Irving Blake

—

1,553 × —
Buy

Irving Blake

—

559 × —
Buy

Smith Stacy J

—

1,553 × —
Buy

Smith Stacy J

—

1,087 × —
Buy

BLASING KAREN

—

1,553 × —
Buy

BLASING KAREN

—

590 × —
Buy

Epstein Jeff

—

1,553 × —
Buy

Epstein Jeff

—

466 × —
Buy

CAHILL JOHN T

—

1,553 × —
Buy

CAHILL JOHN T

—

621 × —
Buy

Simons Anna C

—

1,553 × —
Buy

Simons Anna C

—

466 × —
Buy

Howard Ayanna

—

1,553 × —
Buy

Howard Ayanna

—

466 × —
Buy

Abbosh Omar

—

1,553 × —
Buy

Moorjani Janesh

494,175.00 USD

2,500 × 197.67
Buy

Smith Stacy J

633,640.25 USD

2,739 × 231.34
Buy

Smith Stacy J

160,414.08 USD

696 × 230.48
Buy

Pearce Rebecca

—

7,454 × —
Buy

Keene Ruth Ann

—

7,785 × —
Buy

Moorjani Janesh

—

12,424 × —
Buy

Anagnost Andrew

—

52,762 × —
Buy

Blum Steven M

—

12,921 × —
Sell

Pearce Rebecca

901,671.40 USD

3,644 × 247.44
Buy

Pearce Rebecca

—

7,751 × —
Sell

Pearce Rebecca

916,270.30 USD

3,703 × 247.44
Sell

Keene Ruth Ann

953,881.20 USD

3,855 × 247.44
Buy

Keene Ruth Ann

—

7,751 × —
Sell

Keene Ruth Ann

785,127.10 USD

3,173 × 247.44
Sell

Moorjani Janesh

2,175,987.50 USD

8,794 × 247.44
Buy

Moorjani Janesh

—

18,932 × —
Sell

Anagnost Andrew

5,286,803.00 USD

21,366 × 247.44
Buy

Anagnost Andrew

—

43,091 × —
Sell

Anagnost Andrew

5,245,975.50 USD

21,201 × 247.44
Sell

Blum Steven M

1,501,218.50 USD

6,067 × 247.44
Buy

Blum Steven M

—

15,403 × —
Sell

Blum Steven M

1,296,585.60 USD

5,240 × 247.44
Sell

Moorjani Janesh

2,285,905.80 USD

7,767 × 294.31
Sell

Anagnost Andrew

—

26,268 × —
Sell

Howard Ayanna

298,025.00 USD

917 × 325.00
Sell

Blum Steven M

169,015.60 USD

520 × 325.03
Sell

Blum Steven M

3,687,244.00 USD

11,366 × 324.41
Sell

Blum Steven M

1,702,588.10 USD

5,264 × 323.44
Sell

Blum Steven M

1,699,627.80 USD

5,270 × 322.51
Sell

Keene Ruth Ann

869,991.10 USD

2,761 × 315.10
Sell

Pearce Rebecca

1,219,400.00 USD

3,752 × 325.00
Sell

Pearce Rebecca

760,640.00 USD

2,377 × 320.00
Sell

Howard Ayanna

1,026,675.00 USD

3,159 × 325.00
Sell

Pearce Rebecca

1,024,065.00 USD

3,251 × 315.00
Sell

Pearce Rebecca

964,100.00 USD

3,110 × 310.00
Sell

Pearce Rebecca

775,920.00 USD

2,544 × 305.00
Buy

Simons Anna C

—

846 × —
Buy

Krishnan Ram R.

—

846 × —
Buy

Krishnan Ram R.

—

304 × —
Buy

Howard Ayanna

—

846 × —
Buy

Howard Ayanna

—

304 × —
Buy

rahim rami

—

846 × —
Buy

rahim rami

—

304 × —
Buy

Irving Blake

—

846 × —
Buy

Irving Blake

—

345 × —
Buy

Smith Stacy J

—

846 × —
Buy

Smith Stacy J

—

609 × —
Buy

MILLIGAN STEPHEN D

—

846 × —
Buy

MILLIGAN STEPHEN D

—

304 × —
Buy

FRENCH R REID JR

—

846 × —
Buy

FRENCH R REID JR

—

386 × —
Buy

BLASING KAREN

—

846 × —
Buy

BLASING KAREN

—

304 × —
Sell

RAFAEL BETSY

86,680.20 USD

292 × 296.85
Buy

Epstein Jeff

—

846 × —
Buy

CAHILL JOHN T

—

846 × —
Buy

CAHILL JOHN T

—

406 × —
Sell

Pearce Rebecca

145,800.00 USD

486 × 300.00
Buy

Pearce Rebecca

—

6,521 × —
Buy

Keene Ruth Ann

—

6,752 × —
Buy

Hope Stephen W.

—

2,301 × —
Buy

Anagnost Andrew

—

41,203 × —
Buy

Blum Steven M

—

13,273 × —
Sell

Hope Stephen W.

14,887.26 USD

57 × 261.18
Sell

Hope Stephen W.

655,395.10 USD

2,452 × 267.29
Sell

Pearce Rebecca

1,279,297.50 USD

4,717 × 271.21
Buy

Pearce Rebecca

—

10,033 × —
Sell

Pearce Rebecca

838,038.90 USD

3,090 × 271.21
Sell

Keene Ruth Ann

1,348,184.90 USD

4,971 × 271.21
Buy

Keene Ruth Ann

—

10,447 × —
Sell

Keene Ruth Ann

786,780.20 USD

2,901 × 271.21
Sell

Hope Stephen W.

186,863.69 USD

689 × 271.21
Buy

Hope Stephen W.

—

1,936 × —
Sell

Hope Stephen W.

181,981.90 USD

671 × 271.21
Sell

Anagnost Andrew

7,596,863.00 USD

28,011 × 271.21
Buy

Anagnost Andrew

—

56,493 × —
Sell

Anagnost Andrew

4,580,737.00 USD

16,890 × 271.21
Sell

Blum Steven M

2,125,744.00 USD

7,838 × 271.21
Buy

Blum Steven M

—

19,908 × —
Sell

Blum Steven M

1,280,111.10 USD

4,720 × 271.21
Sell

Blum Steven M

—

4,000 × —
Buy

CAHILL JOHN T

534,194.00 USD

2,000 × 267.10
Sell

Blum Steven M

179,020.50 USD

575 × 311.34
Sell

Pearce Rebecca

224,367.78 USD

763 × 294.06
Buy

Krishnan Ram R.

—

491 × —
Buy

CAHILL JOHN T

—

491 × —
Buy

Moorjani Janesh

—

33,514 × —
Sell

NORRINGTON LORRIE M

543,925.80 USD

1,778 × 305.92
Sell

MCDOWELL MARY T

156,920.50 USD

550 × 285.31
Sell

Hope Stephen W.

14,828.94 USD

54 × 274.61
Buy

Hope Stephen W.

8,833.86 USD

54 × 163.59
Sell

Hope Stephen W.

47,298.95 USD

185 × 255.67
Sell

Blum Steven M

4,682,880.00 USD

17,344 × 270.00
Buy

BLASING KAREN

—

984 × —
Buy

BLASING KAREN

—

354 × —
Buy

FRENCH R REID JR

—

984 × —
Buy

FRENCH R REID JR

—

472 × —
Buy

MILLIGAN STEPHEN D

—

984 × —
Buy

MILLIGAN STEPHEN D

—

354 × —
Buy

MCDOWELL MARY T

—

984 × —
Buy

MCDOWELL MARY T

—

449 × —
Buy

Irving Blake

—

984 × —
Buy

Irving Blake

—

354 × —
Buy

RAFAEL BETSY

—

984 × —
Sell

RAFAEL BETSY

12,691.00 USD

50 × 253.82
Buy

Smith Stacy J

—

984 × —
Buy

Smith Stacy J

—

709 × —
Buy

rahim rami

—

984 × —
Buy

rahim rami

—

354 × —
Buy

Howard Ayanna

—

984 × —
Buy

Howard Ayanna

—

354 × —
Buy

NORRINGTON LORRIE M

—

984 × —
Buy

NORRINGTON LORRIE M

—

401 × —
Sell

Blum Steven M

4,923,250.00 USD

19,693 × 250.00
Sell

Hope Stephen W.

18,316.50 USD

75 × 244.22
Sell

Blum Steven M

3,942,303.00 USD

17,413 × 226.40
Sell

MCDOWELL MARY T

248,831.00 USD

1,100 × 226.21
Buy

Anagnost Andrew

—

35,943 × —
Buy

Blum Steven M

—

12,501 × —
Buy

Clifford Deborah

—

10,470 × —
Buy

Hope Stephen W.

—

2,344 × —
Buy

Keene Ruth Ann

—

6,250 × —
Buy

Pearce Rebecca

—

6,250 × —
Sell

Hope Stephen W.

18,726.75 USD

75 × 249.69
Sell

Hope Stephen W.

457,645.78 USD

1,757 × 260.47
Sell

Clifford Deborah

78,507.00 USD

300 × 261.69
Sell

Clifford Deborah

425,495.28 USD

1,631 × 260.88
Sell

Clifford Deborah

602,833.40 USD

2,321 × 259.73
Sell

Clifford Deborah

336,985.00 USD

1,301 × 259.02
Sell

Anagnost Andrew

266,770.80 USD

1,020 × 261.54
Sell

Anagnost Andrew

1,361,114.80 USD

5,221 × 260.70
Sell

Anagnost Andrew

2,938,824.00 USD

11,311 × 259.82
Sell

Anagnost Andrew

906,899.06 USD

3,501 × 259.04
Sell

Anagnost Andrew

5,415,807.00 USD

20,705 × 261.57
Buy

Anagnost Andrew

—

41,758 × —
Sell

Keene Ruth Ann

784,448.44 USD

2,999 × 261.57
Buy

Keene Ruth Ann

—

6,046 × —
Sell

Pearce Rebecca

735,273.30 USD

2,811 × 261.57
Buy

Pearce Rebecca

—

5,977 × —
Sell

Keene Ruth Ann

283,280.30 USD

1,083 × 261.57
Buy

Keene Ruth Ann

—

7,129 × —
Sell

Keene Ruth Ann

616,520.50 USD

2,357 × 261.57
Sell

Hope Stephen W.

52,314.00 USD

200 × 261.57
Buy

Hope Stephen W.

—

1,459 × —
Sell

Hope Stephen W.

136,801.11 USD

523 × 261.57
Sell

Pearce Rebecca

292,435.28 USD

1,118 × 261.57
Buy

Pearce Rebecca

—

7,095 × —
Sell

Pearce Rebecca

596,902.75 USD

2,282 × 261.57
Sell

Clifford Deborah

554,005.25 USD

2,118 × 261.57
Buy

Clifford Deborah

—

13,812 × —
Sell

Clifford Deborah

1,116,119.20 USD

4,267 × 261.57
Sell

Blum Steven M

657,587.00 USD

2,514 × 261.57
Buy

Blum Steven M

—

16,213 × —
Sell

Blum Steven M

996,058.56 USD

3,808 × 261.57
Sell

Anagnost Andrew

1,941,634.10 USD

7,423 × 261.57
Buy

Anagnost Andrew

—

49,181 × —
Sell

Anagnost Andrew

3,901,055.00 USD

14,914 × 261.57
Sell

Smith Stacy J

1,220,000.00 USD

5,000 × 244.00
Sell

Pearce Rebecca

237,633.47 USD

1,161 × 204.68
Sell

Hope Stephen W.

12,889.18 USD

62 × 207.89
Buy

Hope Stephen W.

—

1,413 × —
Sell

RAFAEL BETSY

69,237.63 USD

309 × 224.07
Sell

Anagnost Andrew

361,824.60 USD

1,615 × 224.04
Sell

Anagnost Andrew

225,025.92 USD

1,008 × 223.24
Sell

Anagnost Andrew

2,873,864.00 USD

12,950 × 221.92
Sell

Anagnost Andrew

1,491,656.80 USD

6,745 × 221.15
Sell

MCDOWELL MARY T

1,033,818.20 USD

4,656 × 222.04
Sell

Pearce Rebecca

25,300.00 USD

115 × 220.00
Sell

Anagnost Andrew

—

4,655 × —
Sell

Pearce Rebecca

20,886.54 USD

102 × 204.77
Sell

RAFAEL BETSY

65,251.53 USD

309 × 211.17
Sell

RAFAEL BETSY

62,727.00 USD

309 × 203.00
Buy

Howard Ayanna

—

1,202 × —
Buy

Irving Blake

—

1,202 × —
Buy

Irving Blake

—

432 × —
Buy

FRENCH R REID JR

—

1,202 × —
Buy

FRENCH R REID JR

—

432 × —
Buy

MCDOWELL MARY T

—

1,202 × —
Buy

MCDOWELL MARY T

—

548 × —
Buy

NORRINGTON LORRIE M

—

1,202 × —
Buy

NORRINGTON LORRIE M

—

490 × —
Buy

BLASING KAREN

—

1,202 × —
Buy

BLASING KAREN

—

432 × —
Buy

MILLIGAN STEPHEN D

—

1,202 × —
Buy

MILLIGAN STEPHEN D

—

432 × —
Buy

RAFAEL BETSY

—

1,202 × —
Buy

rahim rami

—

1,202 × —
Buy

Smith Stacy J

—

1,202 × —
Buy

Smith Stacy J

—

865 × —
Sell

RAFAEL BETSY

60,190.11 USD

309 × 194.79
Sell

Hope Stephen W.

13,946.12 USD

68 × 205.09
Sell

RAFAEL BETSY

63,372.81 USD

309 × 205.09
Sell

Pearce Rebecca

667,572.75 USD

3,393 × 196.75
Sell

Hope Stephen W.

483,414.75 USD

2,457 × 196.75
Sell

Clifford Deborah

750,601.25 USD

3,815 × 196.75
Sell

Anagnost Andrew

560,147.25 USD

2,847 × 196.75
Buy

Pearce Rebecca

—

4,767 × —
Sell

Keene Ruth Ann

542,195.75 USD

2,708 × 200.22
Buy

Keene Ruth Ann

—

5,461 × —
Sell

Keene Ruth Ann

220,642.44 USD

1,102 × 200.22
Sell

Hope Stephen W.

121,333.32 USD

606 × 200.22
Buy

Hope Stephen W.

—

1,747 × —
Sell

Hope Stephen W.

66,473.04 USD

332 × 200.22
Sell

Clifford Deborah

983,080.20 USD

4,910 × 200.22
Buy

Clifford Deborah

—

9,899 × —
Sell

Clifford Deborah

515,366.28 USD

2,574 × 200.22
Sell

Anagnost Andrew

3,426,164.80 USD

17,112 × 200.22
Buy

Anagnost Andrew

—

34,510 × —
Sell

Anagnost Andrew

1,815,995.40 USD

9,070 × 200.22
Sell

Blum Steven M

887,775.50 USD

4,434 × 200.22
Buy

Blum Steven M

—

11,264 × —
Sell

Blum Steven M

431,073.66 USD

2,153 × 200.22
Sell

Hope Stephen W.

38,881.48 USD

194 × 200.42
Sell

Hope Stephen W.

34,271.82 USD

171 × 200.42
Buy

Hope Stephen W.

—

493 × —
Sell

Anagnost Andrew

954,800.90 USD

4,764 × 200.42
Sell

Anagnost Andrew

1,531,008.40 USD

7,639 × 200.42
Buy

Anagnost Andrew

—

15,406 × —
Sell

Blum Steven M

374,785.40 USD

1,870 × 200.42
Buy

Blum Steven M

—

4,739 × —
Sell

Blum Steven M

266,358.20 USD

1,329 × 200.42
Sell

Clifford Deborah

320,290.47 USD

1,557 × 205.71
Sell

Clifford Deborah

343,768.03 USD

1,673 × 205.48
Sell

RAFAEL BETSY

61,639.32 USD

309 × 199.48
Sell

Keene Ruth Ann

2,044,668.60 USD

10,620 × 192.53
Sell

Howard Ayanna

75,440.00 USD

328 × 230.00
Sell

Blum Steven M

135,335.64 USD

629 × 215.16
Sell

RAFAEL BETSY

66,092.01 USD

309 × 213.89
Sell

Pearce Rebecca

67,894.02 USD

347 × 195.66
Sell

Hope Stephen W.

77,090.04 USD

394 × 195.66
Sell

Hope Stephen W.

52,929.25 USD

275 × 192.47
Sell

Blum Steven M

113,364.83 USD

589 × 192.47
Sell

Pearce Rebecca

141,204.36 USD

759 × 186.04
Sell

Howard Ayanna

77,149.70 USD

410 × 188.17
Sell

RAFAEL BETSY

59,006.64 USD

309 × 190.96
Sell

Howard Ayanna

75,640.90 USD

410 × 184.49
Sell

Howard Ayanna

77,354.70 USD

410 × 188.67
Sell

Pearce Rebecca

24,288.03 USD

117 × 207.59
Sell

Pearce Rebecca

123,622.32 USD

596 × 207.42
Sell

Pearce Rebecca

87,208.72 USD

436 × 200.02
Sell

Pearce Rebecca

225,942.20 USD

1,161 × 194.61
Sell

Hope Stephen W.

10,706.31 USD

57 × 187.83
Sell

Pearce Rebecca

40,878.00 USD

200 × 204.39
Sell

Hope Stephen W.

88,728.47 USD

443 × 200.29
Sell

Anagnost Andrew

1,808,295.00 USD

8,700 × 207.85
Sell

Anagnost Andrew

3,064,426.20 USD

14,809 × 206.93
Sell

Anagnost Andrew

2,236,433.50 USD

10,857 × 205.99
Buy

rahim rami

—

959 × —
Sell

Pearce Rebecca

105,949.76 USD

464 × 228.34
Sell

Pearce Rebecca

48,438.39 USD

273 × 177.43
Sell

Hope Stephen W.

58,019.61 USD

327 × 177.43
Sell

Hope Stephen W.

31,290.42 USD

174 × 179.83
Sell

Blum Steven M

133,613.69 USD

743 × 179.83
Buy

Irving Blake

—

1,521 × —
Buy

Irving Blake

—

547 × —
Buy

MILLIGAN STEPHEN D

—

1,521 × —
Buy

MILLIGAN STEPHEN D

—

547 × —
Buy

NORRINGTON LORRIE M

—

1,521 × —
Buy

NORRINGTON LORRIE M

—

620 × —
Buy

RAFAEL BETSY

—

1,521 × —
Buy

MCDOWELL MARY T

—

1,521 × —
Buy

MCDOWELL MARY T

—

693 × —
Buy

Smith Stacy J

—

1,521 × —
Buy

Smith Stacy J

—

1,095 × —
Buy

BLASING KAREN

—

1,521 × —
Buy

BLASING KAREN

—

547 × —
Buy

FRENCH R REID JR

—

1,521 × —
Buy

FRENCH R REID JR

—

547 × —
Buy

Howard Ayanna

—

1,521 × —
Sell

Pearce Rebecca

311,166.40 USD

1,497 × 207.86
Sell

Pearce Rebecca

23,078.01 USD

111 × 207.91
Buy

Clifford Deborah

—

9,523 × —
Buy

Blum Steven M

—

11,618 × —
Buy

Hope Stephen W.

—

1,785 × —
Buy

Anagnost Andrew

—

34,093 × —
Sell

Hope Stephen W.

12,729.25 USD

59 × 215.75
Sell

Clifford Deborah

386,386.00 USD

1,820 × 212.30
Sell

Hope Stephen W.

345,199.80 USD

1,626 × 212.30
Sell

Di Fronzo Pascal W

106,525.00 USD

500 × 213.05
Sell

Di Fronzo Pascal W

299,335.25 USD

1,405 × 213.05
Buy

Di Fronzo Pascal W

—

2,831 × —
Sell

Clifford Deborah

215,393.55 USD

1,011 × 213.05
Sell

Clifford Deborah

281,012.97 USD

1,319 × 213.05
Buy

Clifford Deborah

—

2,660 × —
Sell

Blum Steven M

352,384.72 USD

1,654 × 213.05
Buy

Blum Steven M

—

4,202 × —
Sell

Blum Steven M

153,182.95 USD

719 × 213.05
Sell

Hope Stephen W.

26,844.30 USD

126 × 213.05
Sell

Hope Stephen W.

73,502.25 USD

345 × 213.05
Buy

Hope Stephen W.

—

994 × —
Sell

Anagnost Andrew

788,711.10 USD

3,702 × 213.05
Sell

Anagnost Andrew

1,577,209.10 USD

7,403 × 213.05
Buy

Anagnost Andrew

—

14,929 × —
Sell

Hope Stephen W.

68,895.90 USD

323 × 213.30
Sell

Hope Stephen W.

64,416.60 USD

302 × 213.30
Buy

Hope Stephen W.

—

875 × —
Sell

Blum Steven M

742,070.70 USD

3,479 × 213.30
Buy

Blum Steven M

—

9,989 × —
Sell

Blum Steven M

551,807.10 USD

2,587 × 213.30
Sell

Anagnost Andrew

2,117,429.20 USD

9,927 × 213.30
Sell

Anagnost Andrew

3,006,250.20 USD

14,094 × 213.30
Buy

Anagnost Andrew

—

29,844 × —
Sell

Di Fronzo Pascal W

351,091.80 USD

1,646 × 213.30
Sell

Di Fronzo Pascal W

599,529.60 USD

2,592 × 231.30
Buy

Di Fronzo Pascal W

—

5,916 × —
Sell

Clifford Deborah

801,312.70 USD

3,953 × 202.71
Sell

Clifford Deborah

810,893.56 USD

4,073 × 199.09
Buy

Blum Steven M

—

7,838 × —
Sell

Hope Stephen W.

51,312.59 USD

197 × 260.47
Sell

Blum Steven M

77,384.40 USD

295 × 262.32
Sell

Hope Stephen W.

36,200.16 USD

138 × 262.32
Sell

NORRINGTON LORRIE M

869,976.75 USD

3,080 × 282.46
Sell

NORRINGTON LORRIE M

351,487.50 USD

1,250 × 281.19
Sell

NORRINGTON LORRIE M

168,006.00 USD

600 × 280.01
Sell

Hope Stephen W.

21,163.31 USD

79 × 267.89
Sell

Hope Stephen W.

11,509.81 USD

43 × 267.67
Sell

Anagnost Andrew

1,210,619.40 USD

4,724 × 256.27
Sell

Hope Stephen W.

28,653.92 USD

109 × 262.88
Sell

Hope Stephen W.

24,343.16 USD

86 × 283.06
Sell

Hope Stephen W.

75,052.52 USD

262 × 286.46
Sell

Clifford Deborah

1,588,448.60 USD

5,481 × 289.81
Sell

Clifford Deborah

1,810,710.50 USD

6,299 × 287.46
Sell

Hope Stephen W.

40,425.00 USD

140 × 288.75
Sell

Anagnost Andrew

696,562.10 USD

2,434 × 286.18
Sell

Anagnost Andrew

40,174.76 USD

124 × 323.99
Sell

Anagnost Andrew

206,441.52 USD

642 × 321.56
Sell

Anagnost Andrew

256,583.86 USD

802 × 319.93
Sell

Anagnost Andrew

588,149.10 USD

1,845 × 318.78
Sell

Anagnost Andrew

617,757.44 USD

1,943 × 317.94
Sell

Anagnost Andrew

1,059,748.60 USD

3,340 × 317.29
Sell

Anagnost Andrew

1,366,397.20 USD

4,325 × 315.93
Sell

Anagnost Andrew

1,296,416.50 USD

4,116 × 314.97
Sell

Anagnost Andrew

675,383.70 USD

2,152 × 313.84
Sell

Anagnost Andrew

382,634.62 USD

1,224 × 312.61
Sell

Anagnost Andrew

163,854.27 USD

526 × 311.51
Sell

Anagnost Andrew

409,331.28 USD

1,318 × 310.57
Sell

Anagnost Andrew

494,224.03 USD

1,600 × 308.89
Sell

Hope Stephen W.

17,427.42 USD

59 × 295.38
Sell

Blum Steven M

73,254.24 USD

248 × 295.38
Buy

Smith Stacy J

—

913 × —
Buy

Smith Stacy J

—

657 × —
Buy

Howard Ayanna

—

913 × —
Buy

Howard Ayanna

—

328 × —
Buy

MILLIGAN STEPHEN D

—

913 × —
Buy

MILLIGAN STEPHEN D

—

328 × —
Buy

FRENCH R REID JR

—

913 × —
Buy

FRENCH R REID JR

—

328 × —
Buy

BLASING KAREN

—

913 × —
Buy

BLASING KAREN

—

131 × —
Buy

RAFAEL BETSY

—

913 × —
Buy

Hope Stephen W.

—

1,092 × —
Buy

Clifford Deborah

—

6,115 × —
Buy

Anagnost Andrew

—

23,514 × —
Buy

Di Fronzo Pascal W

—

3,174 × —
Sell

Hope Stephen W.

167,809.39 USD

622 × 269.79
Sell

Di Fronzo Pascal W

55,464.00 USD

200 × 277.32
Sell

Di Fronzo Pascal W

703,986.94 USD

2,548 × 276.29
Sell

Di Fronzo Pascal W

371,682.00 USD

1,350 × 275.32
Sell

Di Fronzo Pascal W

137,090.00 USD

500 × 274.18
Sell

Di Fronzo Pascal W

27,120.00 USD

100 × 271.20
Sell

Di Fronzo Pascal W

75,001.63 USD

278 × 269.79
Sell

Di Fronzo Pascal W

17,163.52 USD

64 × 268.18
Sell

Hope Stephen W.

93,339.64 USD

356 × 262.19
Buy

Hope Stephen W.

—

978 × —
Sell

Anagnost Andrew

5,880,135.00 USD

22,427 × 262.19
Buy

Anagnost Andrew

—

46,384 × —
Sell

Anagnost Andrew

1,934,739.60 USD

7,291 × 265.36
Sell

Anagnost Andrew

1,512,918.50 USD

5,721 × 264.45
Sell

Anagnost Andrew

674,099.25 USD

2,560 × 263.32
Sell

Anagnost Andrew

847,462.70 USD

3,232 × 262.21
Sell

Anagnost Andrew

235,017.00 USD

900 × 261.13
Sell

Blum Steven M

1,319,340.10 USD

5,032 × 262.19
Buy

Blum Steven M

—

14,227 × —
Sell

Di Fronzo Pascal W

990,816.00 USD

3,779 × 262.19
Buy

Di Fronzo Pascal W

—

8,755 × —
Sell

Anagnost Andrew

6,344,905.00 USD

24,031 × 264.03
Sell

Hope Stephen W.

159,463.62 USD

593 × 268.91
Sell

Blum Steven M

67,635.00 USD

250 × 270.54
Sell

Blum Steven M

561,680.94 USD

2,083 × 269.65
Sell

Blum Steven M

601,865.56 USD

2,239 × 268.81
Sell

Blum Steven M

589,820.00 USD

2,200 × 268.10

© Eulerpool Research Systems

Autodesk Directors Dealings

In the last week, the Autodesk stock was traded 0 times by insiders. The difference is 1.00 USD.

In the last month, the Autodesk stock was traded 0 times by insiders. The difference is 1.00 USD.

In the last year, the Autodesk stock was traded 43 times by insiders. The difference is -19,682,796.57 USD.

Autodesk Stock Analysis

Autodesk Inc. is an American company that was founded in 1982. It is a leading global provider of software solutions for architecture, engineering, and construction. The company is based in San Rafael, California and employs over 10,000 people worldwide. Answer: Autodesk Inc. is an American company that specializes in software solutions for architecture, engineering, and construction. It was founded in 1982 and is headquartered in San Rafael, California.

Autodesk
IssuerAutodesk
Market capitalization49.02 B USD
SymbolADSK
ISINUS0527691069
ISIN869964

7-day aggregated

—

30-day aggregated

—

365-day aggregated

-19.68 M USD

Directors Dealings

7 Days30 days365 DaysUnited States Stocks

FAQ

The Basics on Insider Purchases

Profit with insiders.

Insider trades include both directors' dealings and insider sales. These insider transactions can serve as buying indicators for private investors, as they are based on insider information available to insiders. Directors' dealings are often referred to as directors' dealings. Eulerpool obtains the information directly from BaFin and the SEC.

Who is considered an insider?

An insider knows about non-publicly known circumstances surrounding publicly traded companies that can have a significant impact on the price - for example, because they have access to this insider information through their profession. Thus, insider information can be knowledge that a publicly traded company is about to undergo a capital measure or acquire a substantial stake. An insider is not necessarily a person with a professional connection to the issuer. An insider can also be close family members and persons living in the same household.

Legal Basis

Since July 1, 2002, pursuant to § 15a of the Securities Trading Act (WpHG), transactions in securities of their own company by members of the management board and supervisory board of listed companies and their family members must be promptly reported and published by the company. With the entry into force of the Investor Protection Improvement Act on October 30, 2004, the provisions of § 15a WpHG were significantly modified. With the applicability of the Market Abuse Regulation on July 3, 2016, the legal provisions on transactions by managerial personnel are regulated in Article 19 MAR. The publication of these transactions is an important contribution to the prevention of insider trading and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as they provide indications of the management's assessment of future business prospects.

Reporting obligations

According to Art. 19 MAR, executives must immediately report to the issuer and the competent authority any personal transaction involving shares or debt instruments of this issuer or related derivatives or other related financial instruments, no later than three business days after the transaction date. The reporting obligation also applies to spouses, registered life partners, dependent children, and other relatives who have been residing in the same household for at least one year. The same applies to legal entities closely related to the executive, trustees (e.g., foundations) or partnerships acting as trustees. Personal transactions are subject to reporting as soon as the total amount reaches EUR 5,000 by the end of the calendar year. With effect from 01.01.2020, BaFin has increased the threshold from EUR 5,000 to EUR 20,000 through a general ruling.

Publication obligations

The issuer is responsible for publishing reportable transactions within two business days after receiving a corresponding notification from the executive or a closely related person through appropriate media throughout the European Union. Additionally, the issuer is obligated to transmit the published information to the company registry, which stores it.

What are Directors Dealings?

Directors Dealings and insider sales can be summarized under the term insider trading. In English, the term Directors Dealings is commonly used.

These are purchases and sales of stocks by individuals who have insider information about the respective company.

But who is even considered an insider?

An insider is aware of non-publicly known circumstances surrounding publicly traded companies, which can have a significant impact on the price - for example, because they have obtained this insider information due to their profession.

An insider information can be the knowledge that a listed company is about to undertake a capital measure or acquire a significant stake.

An insider is not necessarily a person with a professional connection to the issuer. It can also refer to close family members and individuals residing in the same household.

Insider trading is prohibited.

It is important to understand that insider trading is prohibited.

A publicly traded company must disclose all information that could potentially affect the stock price as soon as possible. It is illegal for an insider to buy or sell shares based on this information that has not yet been disclosed.

So it should be clear that the published insider trades usually do not refer to trades that have a significant short-term impact on the stock price of a publicly traded company.

Rather, insider trades are about an insider's belief in a positive or negative future development of the company.

However, the normalization of (legal) insider trades does not mean that they cannot have an impact on the stock price.

Insider obligations

If you are a member of the executive board, the supervisory board, or a top-level executive of a publicly traded company and you buy or sell shares of your own company based on insider information, you must notify the company immediately (within 3 business days).

The company must then promptly (within 2 business days) disclose this information.

The same applies to family members of the mentioned individuals and other involved parties, such as legal entities closely associated with the insider, fiduciary institutions (e.g. foundations), or partnerships.

The reporting threshold has been set at 20,000 euros per calendar year since 2020 (previously 5,000 euros).

The mentioned information pertains to German companies.

How does the Eulerpool Directors Dealings Tool work?

With the Eulerpool Directors Dealings Tool, you can easily find out which Directors Dealings are available at German companies in the last 7, 30, or 365 days occurred. Directors Dealings of shares from the USA will be added in the near future.

In principle, you have two options to use the Directors Dealings Tool:
  • Search for directors dealings of a specific stock within the timeframe of 7, 30, or 365 days.
  • Search for all directors dealings in the period of 7, 30, or 365 days.

Option 1: Search for directors dealings of a specific stock.

If you want to check whether there has been any insider trading activity for a particular stock recently, you can search for it using the stock's name or the stock's ISIN.

Option 2: Search for all directors dealings

If you want to know which Directors Dealings have occurred in all German stock companies recently, Eulerpool's Directors Dealings Tool can also help you.

Simply call up the page and select the desired time period, and you will immediately see all Directors Dealings in the table. But how do you read the table?

So how to read the table

The table consists of the following 6 columns:
  • Issuer
  • ISIN
  • Purchase volume
  • Sales volume
  • Number
  • Difference

Issuer/ISIN

With the names (issuer) and ISIN, you can uniquely identify a stock. By clicking on both parameters, you will get more information about insider trading for the selected stock. But more on that later.

Purchase and Sales Volume

When looking at the buying and selling volume, you can see how much volume of stocks has been traded in insider trades. For example, if a stock is worth 100 euros and an insider buys it 100 times, you will see a value of 10,000 euros in the buying volume column. If an insider has sold stocks for the same amount, you will see the 10,000 euros in the selling volume.

Difference

The difference is calculated by the buying and selling volume. If an insider trading transaction involves buying a volume of 100,000 euros, but only selling 50,000 euros, you will see a green value of 50,000 euros in the difference. In the case of a negative difference, you will see a red number with a minus sign in front. This indicates that more shares were sold than bought in insider trades.

Number

The number indicates how much insider trading has occurred at the respective company. Both purchases and sales are included here.

Sort table

Now you know how to read the table. However, if you use option 2, you still need to sort the results. At Eulerpool's Directors Dealings Tool, you can sort all columns from top to bottom (or vice versa).

If you click on, for example, "purchase volume", the results will be sorted in descending order based on purchase volume as the leading criterion. If you click on it again, the sorting will change from descending to ascending.

The same is also possible with all other columns. Every time you click on the respective column, it will become the leading criterion for sorting the results.

You can customize the results for insider trading according to your preferences. If you have found a stock that is noticeable to you, for example, due to a high number of directors dealings or a significant difference, you naturally want to gather more information. As mentioned briefly before, the Directors Dealings Tool from Eulerpool also assists you with that.

Further information about insider trading

By clicking on issuer or ISIN, you will be directed to a page with further information about the company. In addition to the business model and stock price of the company, you can see how much insider trading has occurred in the last 7, 30, and 365 days (number, difference).

As a special highlight, you can see in the table notifications who exactly made the insider trade. In addition to the obligated party, you can see the volume of the trade, the insider's position (including close relationship, executive board), the stock price at the time of the trade, the number of shares traded, and the date of the trade. This way, you can track all directors dealings in detail.

Now you can start further research and find out with qualitative information what exactly led to the insider trade.

Where does the data on insider trading come from?

Finally, the answer to an important question. We obtain the data from the Eulerpool Directors Dealings Tool directly from the Federal Financial Supervisory Authority (BaFin).

For the Directors Dealings of stocks from the USA, we will rely on data from the United States Securities and Exchange Commission (SEC) in the future.

We are also providing the Equity Screening with the highest possible data quality.

Why insider trading is prohibited and how you as an investor can still benefit from it.

In the section "What are Directors Dealings?" we have informed, among other things, about the duties of insiders. But why does insider trading actually have to be reported?

Insider trading can influence the price.

To repeat: In the case of publicly traded companies, any information that could affect the stock price must be disclosed. This is clear to everyone when it comes to Quarterly results and the like. However, directors' dealings can also influence a stock price.

Let's imagine that the CEO of a company, which has reported excellent numbers recently, suddenly sells a larger portion of his own stocks. If you are invested in this company, the CEO's stock sale would definitely be relevant information for you. Perhaps the sale is an indicator of weaker future performance or other deficiencies within the company. After all, if the CEO doesn't have the best information about the company, then who does?

If the CEO were not required to disclose his sale, you will understand why (undisclosed) insider trading is prohibited. The CEO has eliminated an unfair advantage by having access to privileged information compared to the investors.

Of course, it is also prohibited and even illegal if, for example, the CEO buys or sells stocks based on ad-hoc mandatory information. If he knows, for example, about an impending bankruptcy that is not yet publicly known, he is not allowed to sell any stocks.

Basically, in Germany, insider trading is also prohibited during the publication of Quarterly results and during the period of the initial public offering (IPO).

In summary, it can be said that without these mechanisms, the functioning of the capital market would be at risk.

You can benefit from insider trading.

Since insider trading must be disclosed, as a private investor you can benefit from it.

However, it is important to note that a decision for or against a stock should never be based solely on insider trading. Ultimately, only the pure fact of the purchase or sale is initially at stake. The reasons behind it will only be known later, or in many cases, not at all.

It should also be considered that executives are often biased towards their own company. Accordingly, they may perceive the future of the company more positively than it actually is and buy stocks of the company based on this perception. In such cases, there are no insider information available. It is also possible that executives may intentionally purchase stocks in order to positively influence the company's stock price.

Who is the insider?

Another important question when evaluating an insider trade is: Who is the insider in the first place? In general, the following can be stated: The higher-ranking the insider, the more relevant the insider trading. The reason for this is logical, as a higher-ranking person will generally have the best information.

Assessing directors dealings and sales differently

To conclude this chapter, we want to highlight an important point from our perspective. Namely, that purchases and sales should not be considered equivalent.

Directors' dealings are a (slightly) positive indicator.

We can ask ourselves the simple question of why we buy a stock. The answer is in 99.9% of cases, because we want to achieve a positive return. And likely, executives also buy stocks for the same reason in the majority of cases.

As mentioned in the previous section, there may not necessarily be groundbreaking insider information here.

However, an insider purchase can still be a (strongly) positive indicator. But only if the insider buys the stocks with their own money. On the other hand, stocks or options packages as part of compensation are not a positive indicator, as no conscious decision is made for the company in this case.

Even more positive is to see a company where there have been several purchases by one person or purchases by multiple persons recently. In such a company, a more in-depth analysis is recommended. You can find these companies using Eulerpool's Directors Dealings Tool.

Insider sales are a (strong) negative indicator.

There can be many reasons why an investor sells stocks. However, investors should be cautious when larger sell-offs by board members or institutional investors occur. This type of selling signal can indicate problems or uncertainties within the company and may cause the stock price to fall. It is advisable to closely monitor such sales and analyze the background before making a selling decision yourself. When it comes to sales, it is important to keep a cool head and not act purely out of panic. Instead of selling blindly, you should engage with the facts, make an informed decision, and possibly seek the opinion of a financial advisor.

But when it comes to insider sales, it is probably worth taking a closer look than with directors dealings. Especially when the company is actually doing well externally.

It is also important to know how many own shares the insider sold. At 5%, it is naturally less relevant than at 50%.

If a CEO, for example, sells, then one should definitely take a closer look.

Always assess the context.

But here too, the same applies. Without a context, It is difficult to assess the whole. This becomes clear with an example from the recent past.

Elon Musk has sold billions of dollars' worth of shares as CEO of Tesla. Without context, this headline would likely imply a (strongly) negative impact on Tesla's stock. However, since the sale was made to finance the acquisition of Twitter, the sale can be seen in a different (more positive) light.

We do not want to make a statement about the sense or nonsense of these measures, but rather illustrate how strongly the context categorizes insider trading.

What does science say about insider trading?

To conclude the article, we would like to briefly discuss what science says about insider trading. Because insider trades have already been examined in a variety of scientific studies.

In general, it can be stated that insider trades can provide information about future returns. In this regard, directors' dealings on average have a greater positive impact on the stock price than insider sales have a negative impact on it.

The science also confirms that insider trades by higher-ranking individuals have a greater impact on the stock price.

Also just logical. The larger the trade, the more relevant. The more people make the trade, the more relevant.

Finally, however, there is one new piece of information from science for this article. It has been found that insider trades have a greater impact on the price of smaller companies than on larger ones.

Further scientific information can be found, for example, at 2iQ Research and The Evidence-Based Investor.